Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Oncolytics Biotech Inc (TSX: ONC ) 1.320 -0.030 (-2.22%) Streaming Delayed Price Updated: 2:30 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 25,154 Open 1.370 Bid (Size) 1.310 (23) Ask (Size) 1.320 (22) Prev. Close 1.350 Today's Range 1.300 - 1.370 52wk Range 1.200 - 3.370 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth June 20, 2024 EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GOVX),(NYSE:GSK),(NASDAQ:AZN),(NYSE:MRK) EQNX::TICKER_END Via FinancialNewsMedia Topics Death Exposures Death Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033 June 20, 2024 EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:KYMR),(NASDAQ:GILD),(OTCQX:RHHBY),(NASDAQ:AMGN) EQNX::TICKER_END Via FinancialNewsMedia Performance YTD -25.00% -25.00% 1 Month -10.81% -10.81% 3 Month -14.84% -14.84% 6 Month -15.38% -15.38% 1 Year -51.11% -51.11% More News Read More Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth June 20, 2024 From FN Media Group LLC Via GlobeNewswire Oncolytics Biotech® Doses First Patient in Study of Pelareorep/FOLFIRINOX Combination Therapy in Pancreatic Cancer June 20, 2024 Via FinancialNewsMedia Exposures Product Safety Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033 June 20, 2024 From FN Media Group LLC Via GlobeNewswire Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032 May 24, 2024 Via FinancialNewsMedia Topics Death Exposures Death Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032 May 24, 2024 From FN Media Group LLC Via GlobeNewswire Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep’s Potential in Pancreatic Cancer and Immunotherapeutic Mechanism of Action May 24, 2024 Via FinancialNewsMedia Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036 May 09, 2024 Via FinancialNewsMedia Oncolytics Biotech® Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic Cancer May 09, 2024 Via FinancialNewsMedia Biotech Innovations Paving the Way in Breast Cancer Fight April 11, 2024 Via FinancialNewsMedia Topics Death Exposures Death Product Safety Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA April 11, 2024 Via FinancialNewsMedia Exposures Product Safety Biotech’s Role in Addressing the Pancreatic Cancer Emergency March 14, 2024 Via FinancialNewsMedia Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market – A Race Worth March 06, 2024 Via FinancialNewsMedia Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning March 06, 2024 Via Newsfile Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN March 05, 2024 Via FinancialNewsMedia Cancer Immunotherapy Stocks – Tapping into Immune Systems for Next Generation Treatments February 15, 2024 Via FinancialNewsMedia Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments March 05, 2024 Via FinancialNewsMedia Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments February 15, 2024 Via Newsfile Oncolytics Biotech® Initiates Enrollment Expansion of GOBLET Anal Cancer Cohort February 14, 2024 Via FinancialNewsMedia Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments March 05, 2024 From FN Media Group LLC Via GlobeNewswire Pancreatic Cancer Treatments Poised for Major Advances in 2024 February 07, 2024 Via FinancialNewsMedia Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies February 14, 2024 Via FinancialNewsMedia Stocks Recoup Post-Fed Losses As Traders Challenge Powell, Regional Banks Crack, Gold Rises: What's Driving Markets Thursday? February 01, 2024 Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies February 14, 2024 From FN Media Group LLC Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.